ILA.AX

Island Pharmaceuticals Limited ILA.AX

ILA.AX
Island Pharmaceuticals Limited ACW.AX
Actinogen Medical Limited NYR.AX
Nyrada Inc. RAD.AX
Radiopharm Theranostics Limited BIO.AX
Biome Australia Limited ALA.AX
Arovella Therapeutics Limited SPL.AX
Starpharma Holdings Limited IMU.AX
Imugene Limited ATX.AX
Amplia Therapeutics Limited ATH.AX
Alterity Therapeutics Limited

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ILA.AX ACW.AX NYR.AX RAD.AX BIO.AX ALA.AX SPL.AX IMU.AX ATX.AX ATH.AX
6M 124.24 % 3.45 % 245.45 % 76.19 % 4.49 % 21.79 % 187.88 % -54.75 % 169.23 % 33.33 %
YTD 124.24 % 15.38 % 313.04 % 54.17 % -22.50 % -44.12 % 159.09 % -69.92 % 50.54 % 33.33 %
1Y 111.43 % 11.11 % 181.48 % 42.31 % -30.60 % -50.00 % 200.00 % -76.05 % -6.67 % 300.00 %
3Y 134.38 % -72.46 % 192.31 % -75.44 % 511.84 % 227.59 % -55.81 % -93.08 % 45.50 % -7.69 %
5Y -24.10 % 29.25 % 85.37 % -89.63 % 287.50 % 131.71 % -80.87 % -78.61 % -33.83 % -75.00 %
10Y -24.10 % -48.71 % 61.70 % -89.63 % 287.50 % -82.24 % -60.42 % 31.89 % -91.14 % -90.40 %
From the beginning -24.10 % -95.44 % 61.70 % -89.63 % 287.50 % -97.10 % -66.47 % -99.52 % -92.05 % -97.60 %

Dividend